Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Cognitive impairment in schizophrenia

Much of the current knowledge about cognitive impairment in schizophrenia... [Pg.229]

Tugal O, Yazici KM, Yagcioglu AE, Gogus A. 2004. A doubleblind, placebo controlled, cross-over trial of adjunctive donepezil for cognitive impairment in schizophrenia. Int J Neuropsychopharmacol 7 117-123. [Pg.37]

Elvevag B, Goldberg TE. 2000. Cognitive impairment in schizophrenia is the core of the disorder. Crit Rev Neuro-biol 14 1-21. [Pg.225]

Humphries C, Mortimer A, Hirsch S, de Belleroche J. 1996. NMDA receptor mRNA correlation with antemortem cognitive impairment in schizophrenia. Neuroreport 7 2051-2055. [Pg.482]

Keilp JG, Sweeney JA, Jacobsen P, Solomon C, St. Louis L, et al. 1988. Cognitive impairment in schizophrenia Specific relations to ventricular size and negative symptomatology. Biol Psychiatry 24 47-55. [Pg.521]

Johnstone EC, Crow TJ, Frith CD, Stevens J and Kreel L (1976). Cerebral ventricular size and cognitive impairment in chronic schizophrenia. Lancet, 1, 924-926. [Pg.269]

According to this model, a discussion of potential therapeutic drug effects on cognitive function in schizophrenia should focus upon the correction of abnormalities in thought and speech. Other authors, e.g. Schultz and Andreasen (1999), appear to subsume a much wider range of schizophrenic symptoms under the umbrella of cognitive abnormalities Several cognitive and emotional functions are impaired, such as perception (hallucinations),... [Pg.228]

Egan. M.F., Goldberg, T.E., Gscheidle, T., et a . Relative risk for cognitive impairments in siblings of patients with schizophrenia. Biol. Psychiatry 50, 98-107, 2001. [Pg.340]

Buchanan RW, Summerfelt A, Tek C, Gold J. 2003. An open-labeled trial of adjunctive donepezil for cognitive impairments in patients with schizophrenia. Schizophr Res 59 29-33. [Pg.31]

Lee BJ, Lee JG, Kim YH. 2007. A 12-week, double-blind, placebo-controlled trial of donepezil as an adjunct to halo-peridol for treating cognitive impairments in patients with chronic schizophrenia. J Psychopharmacol 21 421-427. [Pg.34]

Weiser M, Javitt DC, Heresco-Levy U, Abramovitch A, Teitlebaum A, et al. 2008. D-serine vs. placebo in the treatment of negative symptoms and cognitive impairment of schizophrenia. Schiz Res 102 8. [Pg.88]

Powell KJ, Hori SE, Leslie R, Andrieux A, Schellinck H, et al. 2007. Cognitive impairments in the STOP null mouse model of schizophrenia. Behav Neurosci 121 826-835. [Pg.234]

Cabungcal JH, Preissman D, Delseth C, Cuenod M, Do KQ, et al. 2007. Transitory glutathione deficit during brain development induces cognitive impairment in juvenile and adult rats Relevance to schizophrenia. Neurobiol Dis 26 634-645. [Pg.303]

Buchanan RW, Conley RR, Dickinson D, Ball MP, Feldman S, Gold JM, Mcmahon RP (2008) Galantamine for the treatment of cognitive impairments in people with schizophrenia. Am J Psychiatry 165 82-89. [Pg.153]

See other pages where Cognitive impairment in schizophrenia is mentioned: [Pg.553]    [Pg.370]    [Pg.507]    [Pg.238]    [Pg.553]    [Pg.370]    [Pg.507]    [Pg.238]    [Pg.279]    [Pg.229]    [Pg.100]    [Pg.292]    [Pg.496]    [Pg.503]    [Pg.255]    [Pg.321]    [Pg.395]    [Pg.512]    [Pg.300]    [Pg.215]    [Pg.1491]    [Pg.1492]    [Pg.16]    [Pg.17]    [Pg.357]    [Pg.549]    [Pg.551]    [Pg.98]    [Pg.157]    [Pg.157]    [Pg.163]    [Pg.19]    [Pg.876]    [Pg.878]   
See also in sourсe #XX -- [ Pg.549 , Pg.551 ]



SEARCH



Cognition impaired

Cognitive impairment

Impaired

Impairment

Schizophrenia cognitive

Schizophrenia cognitive impairment

© 2024 chempedia.info